Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03975166
Brief Title: A Bioequivalence Study Between Fluticasone Propionate 100 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 Inhalation Powder/GSK in Healthy Volunteers

First Submitted : June 3, 2019
First Submitted that Met QC Criteria : June 3, 2019
First Posted : June 5, 2019

Last Update Submitted that Met QC Criteria : September 9, 2019
Last Update Posted : September 10, 2019